Skip to the page

Data / Form D filings / Q Bio, Inc.

Q Bio, Inc.: Form D filing

Q Bio, Inc., a technology company in San Carlos, CA, filed a Form D with the SEC in 2024. The latest, on July 26, 2024, reports $27.1 million sold of a $27.1 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1411 INDUSTRIAL ROAD, San Carlos, CA, 94041
Phone
(415) 967-7622
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2020139

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 26, 2024New notice$27,103,721$27,103,72114Mar 26, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Terry DoyleDirector
Vijay Pande, Ph.D.Director
Clarissa ShenExecutive Officer
Jeffrey KaditzExecutive Officer, Director, Promoter

Other technology companies in California that filed recently

Every Form D from the week of Jul 22, 2024 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Q Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.